Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00873548
Other study ID # PFNA_Asia
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 2007
Est. completion date March 2012

Study information

Verified date January 2013
Source AO Innovation Translation Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of this prospective multicenter study is to assess any fracture fixation complication and revision rates during the clinical use of the Proximal Femoral Nail Antirotation Asia (PFNA Asia) for the treatment of unstable trochanteric fractures.


Description:

From several studies, e.g. on hip prostheses, it is known that the Asian population has other geometric proportions than Caucasians, e.g. Japanese woman have shorter femoral necks, smaller femoral neck angles and a more anterior bowing of the shaft than white Americans. This was one of the reasons for the development of a new PFNA Asia with adapted sizes and geometry. No controlled clinical data are available whether the rate of mismatch and mismatch-related complications could be reduced.


Recruitment information / eligibility

Status Completed
Enrollment 245
Est. completion date March 2012
Est. primary completion date December 2011
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Age 65 years and older - Patients with isolated, unstable, closed trochanteric fractures, classified as AO 31-A2 or AO 31-A3 - Definitive primary fracture treatment with PFNA Asia within 7 days sustaining the fracture (conversion from an external fixator to the PFNA Asia as an emergency procedure within the first week after the accident is allowed) - Signed written informed consent (by the subjects or legal guardian) and agreement to attend the planned follow-ups - Willing and able to comply with the post-operative management program - Able to understand and read country national language at an elementary level Exclusion Criteria: - Pathologic fracture - Patients or legal guardian refusing to sign the informed consent form - Patients with previous implants on the fractured hip and femur - Drug or alcohol abuse - Active malignancy - ASA class V and VI - Patients who are bed-ridden or wheel-chair ridden prior to injury event - Neurological disorders and psychiatric disorders that would preclude reliable assessment (e.g., Parkinson disease, Multiple sclerosis, severe depression) - Patients who have participated in any other device or drug related clinical trial within the previous month

Study Design


Related Conditions & MeSH terms


Intervention

Device:
PFNA-Asia
The operation is performed under regional or general anesthesia and involves the following main steps: Positioning of the patient Definition of the CCD-angle Fracture reduction Determination of the nail diameter Incision Insertion of the device

Locations

Country Name City State
Japan Toyama Municipal Hospital Toyama

Sponsors (2)

Lead Sponsor Collaborator
AO Clinical Investigation and Publishing Documentation Synthes Inc.

Country where clinical trial is conducted

Japan, 

References & Publications (4)

Nakamura T, Turner CH, Yoshikawa T, Slemenda CW, Peacock M, Burr DB, Mizuno Y, Orimo H, Ouchi Y, Johnston CC Jr. Do variations in hip geometry explain differences in hip fracture risk between Japanese and white Americans? J Bone Miner Res. 1994 Jul;9(7):1071-6. — View Citation

Schipper IB, Marti RK, van der Werken C. Unstable trochanteric femoral fractures: extramedullary or intramedullary fixation. Review of literature. Injury. 2004 Feb;35(2):142-51. Review. — View Citation

Simmermacher RK, Bosch AM, Van der Werken C. The AO/ASIF-proximal femoral nail (PFN): a new device for the treatment of unstable proximal femoral fractures. Injury. 1999 Jun;30(5):327-32. — View Citation

Simmermacher RK, Ljungqvist J, Bail H, Hockertz T, Vochteloo AJ, Ochs U, Werken Cv; AO - PFNA studygroup. The new proximal femoral nail antirotation (PFNA) in daily practice: results of a multicentre clinical study. Injury. 2008 Aug;39(8):932-9. doi: 10.1016/j.injury.2008.02.005. Epub 2008 Jun 25. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Bone/fracture- or implant/surgery-related fracture fixation complication events 6 and 12 weeks, 6 and 12 months
Secondary Mismatch Perioperatively
Secondary Soft tissue/wound -related or general complications 6 and 12 weeks, 6 and 12 months
Secondary Health-related quality of life assessed by the generic SF-36-instrument and EQ-5D Baseline, 6 and 12 months
Secondary Walking ability (Parker mobility score) Baseline, 6 and 12 months
Secondary Range of motion (ROM) 6 and 12 weeks, 6 and 12 months
Secondary Mortality 6 and 12 weeks, 6 and 12 months
Secondary Surgery details and postoperative treatment till 12 weeks after surgery
Secondary Length of hospital stay till 12 weeks after surgery
Secondary Capacity to return to pre-residential status 12 weeks
Secondary Bone consolidation and anatomical restoration 6 and 12 weeks, 6 and 12 months
See also
  Status Clinical Trial Phase
Withdrawn NCT00741182 - Effect of PTH(1-34) Treatment on Fracture Healing in Vivo Phase 2
Completed NCT02294747 - Trochanteric Hip Fractures (AO A2) SHS With or Without Trochanteric Stabilizing Plate - Rct Using RSA N/A
Enrolling by invitation NCT05587244 - G7 Freedom Constrained Vivacit-E Liners N/A
Recruiting NCT02672696 - Interest of Navigation for the Treatment of Pertrochanteric Fractures With the Gamma 3 Nail N/A
Enrolling by invitation NCT05548972 - G7 Dual Mobility With Vivacit-E or Longevity PMCF N/A
Not yet recruiting NCT03531983 - Results of Gamma Nail in Trochentric Fractures of the Adults
Recruiting NCT05362864 - ZNN Bactiguard Cephalomedullary Nails PMCF Study
Terminated NCT03382665 - Post-market Surveillance Study With the HYPERION Hip Endoprosthesis System in Defect Reconstruction
Not yet recruiting NCT05677191 - PFNA vs Dual Mobility in Treatment of Unstable Trochanteric Fractures Phase 2
Active, not recruiting NCT05144191 - Insignia™ Hip Stem Outcomes Study N/A
Recruiting NCT05781815 - Treatment Of Unstable Trochanteric Fracture: A Comparative Study Between DHS And DHS With Trochanteric Stabilization Plate N/A
Active, not recruiting NCT03266874 - G7 BiSpherical Acetabular Shell PMCF Study